Veradigm Inc. (MDRX) |
| 4.775 0.025 (0.53%) 01-13 13:52 |
| Open: | 4.15 |
| High: | 4.775 |
| Low: | 4.15 |
| Volume: | 332 |
| Market Cap: | 811(M) |
| PE Ratio: | -26.53 |
| Exchange: | Other OTC |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 6.00 |
| Resistance 1: | 5.29 |
| Pivot price: | 4.81 |
| Support 1: | 4.15 |
| Support 2: | 3.45 |
| 52w High: | 10 |
| 52w Low: | 3 |
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
| EPS | 0.860 |
| Book Value | 10.770 |
| PEG Ratio | -0.64 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 3.97 |
| Operating Margin (%) | 16.59 |
| Return on Assets (ttm) | 2.2 |
| Return on Equity (ttm) | 8.9 |
Mon, 12 Jan 2026
Veradigm (NASDAQ:MDRX) Shares Gap Down - Here's What Happened - MarketBeat
Thu, 08 Jan 2026
Veradigm (NASDAQ:MDRX) Sees Large Volume Increase - What's Next? - MarketBeat
Thu, 01 Jan 2026
Veradigm Extends Interim CFO Tenure Amid Leadership Transition - The Globe and Mail
Wed, 31 Dec 2025
The Truth About Veradigm Inc: Quiet Delisting, Big Healthcare Data Plot Twist - AD HOC NEWS
Mon, 03 Nov 2025
Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer - Business Wire
Tue, 30 Sep 2025
Veradigm reports Q2 revenue decline, completes convertible notes repurchase - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |